Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers
Authors
Keywords
-
Journal
ACTA ONCOLOGICA
Volume 55, Issue 9-10, Pages 1168-1174
Publisher
Informa UK Limited
Online
2016-06-23
DOI
10.1080/0284186x.2016.1191670
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
- (2015) J. S. Chen et al. ANNALS OF ONCOLOGY
- Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues
- (2015) Bertrand Brieau et al. CANCER
- Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial
- (2014) David Malka et al. LANCET ONCOLOGY
- Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review
- (2014) Frédéric Fiteni et al. Cancer Medicine
- Efficacy of gemcitabine plus platinum agents for biliary tract cancers
- (2013) Rui Yang et al. ANTI-CANCER DRUGS
- FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma
- (2013) Roberto Moretto et al. ANTI-CANCER DRUGS
- A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer
- (2013) Sang Myung Woo et al. Gut and Liver
- A Retrospective Study of Chemotherapy with Cisplatin Plus Gemcitabine After the Failure of Gemcitabine Monotherapy for Biliary Tract Cancer
- (2013) R. Kameda et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy for cholangiocarcinoma: An update
- (2013) Natalia Ramírez-Merino World Journal of Gastrointestinal Oncology
- Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study
- (2011) Jeeyun Lee et al. LANCET ONCOLOGY
- Experience of Gemcitabine plus Oxaliplatin Chemotherapy in Patients with Advanced Biliary Tract Carcinoma
- (2010) Antoine Hollebecque et al. CHEMOTHERAPY
- Safety and efficacy of single-day GemOx regimen in patients with pancreatobiliary cancer: a single institution experience
- (2010) Jia Li et al. Expert Opinion On Drug Safety
- Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness
- (2010) Sung Yong Oh et al. INVESTIGATIONAL NEW DRUGS
- Best Supportive Care Compared With Chemotherapy for Unresectable Gall Bladder Cancer: A Randomized Controlled Study
- (2010) Atul Sharma et al. JOURNAL OF CLINICAL ONCOLOGY
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer
- (2009) Hyun Jung Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial
- (2009) Joung-Soon Jang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study
- (2008) T André et al. BRITISH JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation